Stem cell implant stalls progression of dry AMD

image.axd?id=36cab825-92d8-4771-b1fd-318a3d2a71c8&t=636586260669870000
APR 06, 2018 By Keng Jin Lee Science Translational Medicine, University of Southern California Comprehensive Ophthalmology, Retina/Vitreous
Researchers from University of Southern California (USC) are the first to show the feasibility of a stem cell-based implant in people with advanced dry AMD, with no adverse events noted through 1 year. “Our study shows that this unique stem cell-based retinal implant thus far is well tolerated, and preliminary results suggest it may help people with advanced dry age-related macular degeneration,” said co-author and lead inventor of the implant Mark S. Humayun, MD, director of the USC Institute for Biomedical Therapeutics and co-director of the Roski Eye Institute. Results from the phase 1/2a study, funded in part by the California Institute for Regenerative Medicine, appeared March 4 in Science Translational Medicine. Stem cell researchers from the University of California at Santa Barbara also contributed to the high-profile study. The paper marks the second high-profile stem cell study in recent weeks. Last month, surgeons from Moorfields Eye Hospital in London successfully restored reading vision in 2 patients with advanced wet AMD using a specially engineered patch of retinal pigment epithelium (RPE) cells. Both studies used human embryonic stem cell (hESC)-derived RPE cells and similar-size implants, but the researchers opted for different basement layers. Moorfields’ surgeons grew their hESC-RPE cells on a human vitronectin-coated polyester membrane, whereas the USC study used synthetic parylene. The USC investigators say their substrate permits RPE adhesion in a polarized monolayer and a diffusion barrier similar to Bruch’s membrane. The 3.5 x 6.25 mm-sized implant, which housed approximately 100,000 mature, polarized, pigmented hESC-RPE cells, was delivered to 5 patients with geographic atrophy secondary to dry AMD. The procedure was successful in 4 patients. Following surgery, OCT imaging showed changes consistent with hESC-RPE and host-photoreceptor integration. A preliminary assessment of the therapy’s efficacy showed that 1 eye improved by 17 letters and 2 eyes demonstrated improved fixation. Importantly, none showed progressive vision loss. “This is the first human trial of this novel stem cell-based implant, which is designed to replace a single-cell layer that degenerates in patients with dry age-related macular degeneration,” said lead author and surgeon for the study Amir H. Kashani, MD, assistant professor of clinical ophthalmology at the Keck School of Medicine. “This implant has the potential to stop the progression of the disease or even improve patients’ vision. Proving its safety in humans is the first step in accomplishing that goal.”

https://www.lvcenter4sight.com/stem-cell-implant-stalls-progression-of-dry-amd/

Comments

Post a Comment

Popular posts from this blog

Post-LASIK Refraction and Pregnancy – Much Ado About Nothing?

Image
Written by Dr. David Evans Last modified on August 23, 2018 During pregnancy, women experience a drastic shift in their hormonal balance that has a ripple effect throughout the body. The spike in hormones like progesterone, estrogen, prolactin, oxytocin and relaxin are all important for a healthy pregnancy, but these increased levels can also impact gastrointestinal processes, blood pressure, skin pigmentation and, you guessed it, ocular health. Due to refractive changes that often occur during pregnancy, most refractive surgeons advise against LASIK during pregnancy, instead suggesting women wait several months after giving birth before considering treatment. Women who have already undergone LASIK may then wonder if the changes in ocular health that can occur during and after pregnancy impact post-LASIK refraction. New research presented by John Kanellopoulos, MD, New York University Medical School, NY, and LaserVision.gr seems to throw cold water on any such concern. The Eyes an
Read more

I Spy a Stye in Your Eye

Image
Written by Dr. David Evans Last modified on August 6, 2018 What’s that small, red, pimple-like bump on your eyelid that’s causing so much discomfort? It’s probably a stye (sometimes referred to as a sty or hordeolum). Besides being difficult to say 5 times quickly, an eye stye is a type of localized infection that can occur along the base of your eyelashes or underneath your eyelid. Styes that form along the base of the eyelashes are called external styes. They typically occur as a result of an infected eyelash hair follicle and look like the type of pimple that occurs when your pores are clogged with dirt and oil. Styes that form inside the eyelid are called internal styes. Similar to external styes, they are caused by an infection of an oil-producing gland behind the eyelid rather than an eyelash hair follicle. Internal styes result in generalized swelling of the eyelid rather than forming a pimple-like bump. Stye Symptoms As a stye develops, you might begin to experience pain
Read more